| Literature DB >> 31564841 |
Marcel Ballin1,2, Emmy Lundberg1,2, Niklas Sörlén1,2, Peter Nordström1, Andreas Hult2, Anna Nordström2,3.
Abstract
PURPOSE: To explore the effects of 10 weeks of progressive vigorous interval training as a single intervention on health-related quality of life (HRQoL) and cardiometabolic risk markers in centrally obese 70-year-old individuals. PARTICIPANTS AND METHODS: A randomized controlled trial (ClinicalTrials.gov registration no. NCT03450655) including seventy-seven community-dwelling 70-year-old men and women with central obesity defined as > 1 kg visceral adipose tissue for women and > 2 kg for men. Participants randomized to the intervention group were offered a 10-week progressive vigorous interval training program performed three times per week. Control subjects were asked to maintain their daily living and routines throughout the trial. All participants in both groups had received tailored lifestyle recommendations focused on diet and physical activity at one occasion within 12 months prior to trial initiation. Prespecified outcome measures included: changes in HRQoL using the Short Form Health Survey Questionnaire (SF-36), blood pressure; resting heart rate (HR) and blood lipids. All analyses were conducted on an intention-to-treat basis.Entities:
Keywords: ageing; blood lipids; exercise; perceived health
Mesh:
Year: 2019 PMID: 31564841 PMCID: PMC6732517 DOI: 10.2147/CIA.S213133
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Figure 1Study flow chart previously provided as supporting online information in Ballin et al 2019.27
Changes in outcomes during the 10-week study period
| Within-group changes | Between-group changes | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Intervention n=36 | Control n=36 | Intervention n=36 | Control n=36 | ||||||
| Baseline | 10 Weeks | Baseline | 10 Weeks | Mean change | Mean change | ||||
| Social functioning | 94.4±14.0 | 95.7±13.0 | 0.4 | 97.1±8.7 | 94.8±12.6 | 0.5 | 1.3±9.6 | −2.3±16.0 | 0.4 |
| Emotional role limitations | 90.7±26.0 | 89.8±29.6 | 0.8 | 95.8±14.0 | 85.4±33.8 | 0.10 | −0.9±24.5 | −10.4±35.4 | 0.3 |
| Vitality | 73.9±17.5 | 79.0±15.7 | 0.006 | 78.0±13.3 | 76.4±16.8 | 0.6 | 5.1±10.3 | −1.6±10.0 | 0.015* |
| Mental health | 80.6±18.1 | 83.9±15.8 | 0.085 | 85.9±9.3 | 81.6±10.5 | 0.011 | 3.3±11.0 | −4.3±8.1 | 0.007 |
| Component summary | 84.9±16.6 | 87.1±16.7 | 0.081 | 89.1±7.4 | 84.6±16.5 | 0.15 | 2.2±10.9 | −4.6±13.5 | 0.040 |
| Physical functioning | 85.7±10.8 | 89.2±11.0 | 0.036 | 88.1±10.5 | 86.4±14.1 | 0.5 | 3.5±10.9 | −1.7±9.9 | 0.072 |
| Physical role limitations | 85.4±28.9 | 90.3±26.3 | 0.4 | 89.1±24.5 | 86.7±31.7 | 0.7 | 4.9±39.1 | −2.3±39.3 | 0.6 |
| Bodily pain | 70.2±22.9 | 71.1±25.6 | 0.8 | 74.9±20.6 | 72.6±23.5 | 0.7 | 0.9±21.2 | −2.3±20.5 | 0.7 |
| General health | 74.5±16.1 | 78.6±18.3 | 0.081 | 78.1±12.3 | 77.6±12.6 | 0.6 | 4.1±11.1 | −0.5±9.2 | 0.2 |
| Component summary | 79.0±15.3 | 82.3±16.8 | 0.071 | 82.6±12.4 | 80.8±17.0 | 0.6 | 3.3±17.6 | −1.7±14.8 | 0.4 |
| SBP (mmHg) | 143±14 | 136±14 | <0.001 | 136±15 | 131±13 | 0.03 | −7.3±11.8 | −5.1±13.4 | 0.8 |
| DBP (mmHg) | 84±7 | 80±9 | <0.001 | 83±7 | 81±7 | 0.065 | −4.2±6.8 | −2.1±6.6 | 0.2 |
| Resting HR (bpm) | 66±11 | 64±10 | 0.18 | 66±6 | 67±8 | 0.13 | −2.1±9.3 | 1.8±7.1 | 0.045 |
| TC | 5.18±1.25 | 4.93±1.17 | 0.006 | 4.85±0.79 | 5.00±0.92 | 0.18 | −0.25±0.51 | 0.15±0.66 | 0.012 |
| HDL | 1.40±0.42 | 1.39±0.36 | 0.7 | 1.50±0.43 | 1.53±0.39 | 0.2 | −0.01±0.18 | 0.03±0.16 | 0.079 |
| LDL | 3.08±1.09 | 2.89±0.99 | 0.010 | 2.57±0.82 | 2.74±0.89 | 0.075 | −0.18±0.40 | 0.16±0.51 | 0.014 |
| TG | 1.55±0.45 | 1.47±0.42 | 0.3 | 1.77±0.89 | 1.54±0.48 | 0.055 | −0.08±0.42 | −0.24±0.72 | 0.9 |
Notes: Data are presented as group means ± SD. *Not statistically significant after Bonferroni correction.
Abbreviations: HRQoL, health-related quality of life; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides; BPM, beats per minute.
Figure 2Mean changes and 95% confidence intervals for SF-36 raw scores across all subscales and component summaries from baseline to follow-up for the intervention group compared to the control group. P-values are derived from ANCOVA on mean change from baseline to follow-up adjusted for baseline values.
Abbreviations: BP, bodily pain; CI, confidence interval; GH, general health; MCS, mental component summary; MH, mental health; PCS, physical component summary; PF, physical functioning; RE, emotional role functioning; RF, physical role functioning; SF, social functioning; VT, vitality.
Figure 3Mean percentage changes in cardiometabolic risk markers in the study groups following the 10-week intervention period. Error bars represent standard errors of the mean. P-values are derived from ANCOVAs on mean change from baseline to follow-up in percent adjusted for baseline values.
Abbreviations: DBP, diastolic blood pressure; HDL, high-density lipoprotein; HR, heart rate; LDL, low-density lipoprotein; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.